Decipher Labs Ltd vs SUN PHARMACEUTICAL IND L

A side-by-side comparison of Decipher Labs Ltd (DECIPHER) and SUN PHARMACEUTICAL IND L (SUNPHARMA) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

On the numbers, SUN PHARMACEUTICAL IND L leads DECIPHER vs SUNPHARMA on 11 of 14 metrics (1 undecided). See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).

  • Valuation22
  • Profitability04
  • Growth01
  • Size & financial health04

Valuation

Even

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

-1.90
P/E ratio
36.46
0.28
P/B ratio
5.35
0.00%
Dividend yield
0.86%
₹-3.05
EPS
₹47.80

Profitability

SUNPHARMA takes 4/4

How efficiently each company turns capital and sales into profit. Higher is better.

-37.43%
Return on equity
13.74%
-42.14%
Return on capital
17.46%
-24.12%
EBITDA margin
30.33%
-21.95%
Net margin
19.69%

Growth

SUNPHARMA takes 1/2

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

-32.44%
Revenue CAGR (3Y)
10.03%
—
Profit CAGR (3Y) even
10.57%

Size & financial health

SUNPHARMA takes 4/4

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹6 Cr
Market cap
₹4.18L Cr
₹14 Cr
Revenue
₹58,462 Cr
₹-3 Cr
Net profit
₹11,509 Cr
0.06
Debt / equity
0.06
Decipher Labs Ltd
  • + ["Company is almost debt free.", "Stock is trading at 0.67 times its book value"]
  • − ["The company has delivered a poor sales growth of -24.0% over past five years.", "Company has a low return on equity of -16.7% over last 3 years.", "Company reported a net loss of ₹3 Cr in its latest financial year."]
SUN PHARMACEUTICAL IND L
  • + ["Company has delivered good profit growth of 38.3% CAGR over last 5 years", "Company has been maintaining a healthy dividend payout of 33.4%", "Company is almost debt free."]
  • − ["Stock is trading at 5.00 times its book value"]
Decipher Labs Ltd full analysis SUN PHARMACEUTICAL IND L full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.